A Banner interventional cardiologist created a new device that can replace damaged heart valves in patients who are too sick for surgery.
Paul Sorajja, MD, an international cardiologist at Banner-University Medical Center Phoenix, made history in 2016 as the first physician in the world to use a specialized mitral device to treat patients with severe mitral annular calcification — a condition wherein dangerous calcium buildup around the valve makes traditional surgery life-threatening, according to an Oct. 27 system news release. His device, Tendyne, can be placed through a small incision between the ribs and allows patients to go home within a week of surgery. In a study, significant improvements in heart failure symptoms and quality of life were observed in nine of 10 patients.
Tendyne is now the first FDA-approved device for patients with mitral annular calcification, which affects up to 30% of older Americans.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
